Graph AI Raises $13.3 Million to Make Patient Safety Work Faster and Smarter

Graph AI has raised $13.3 million in Series A funding, marking a fresh push for AI in the pharmaceutical safety space. The round was led by Insight Partners, with participation from existing investor Bessemer Venture Partners.

The startup is not building a regular chatbot or a general AI tool. Its focus is more specific. Graph AI wants to help pharma and biotech companies handle patient safety work faster, with better tracking and human review where it matters.

What Graph AI Does

Graph AI builds a platform called Graph Safety. It is made for pharmacovigilance, which simply means the process of tracking and reporting side effects, adverse events, and safety issues linked to medicines.

For example, if a patient reports a serious side effect after taking a medicine, a pharma company has to collect that information, check it, process it, and report it properly. This can take a lot of manual work, especially when reports come through emails, call centers, forms, doctors, hospitals, and other channels.

Graph Safety aims to bring these steps into one AI-supported system. The goal is not to remove safety experts, but to reduce repetitive tasks so they can spend more time on analysis and decisions.

Founders and Startup Background

Graph AI was founded in 2024 by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar.

Raghav Parvataraju is the CEO of the company. The startup has positioned itself around patient safety operations for pharma and biotech firms, a market where accuracy, audit trails, and regulatory compliance are extremely important.

Funding Purpose

The new Graph AI Series A funding will mainly be used to expand the company across the United States and Europe. This is important because pharma safety work is global, and companies need systems that can support different markets and regulatory expectations.

Graph AI has already launched two modules. One helps capture and sort incoming adverse-event reports. Another works as an intelligent safety database for case processing. The company is also preparing a reporting module and is working on signal detection, which can help spot early safety patterns across cases.

In simple words, the funding gives Graph AI more room to build its product, grow its team, support enterprise customers, and enter bigger markets.

Why This Funding Matters

Patient safety is one of the less flashy but very important areas of healthcare. When medicine use grows, safety reports also increase. Many teams still depend on older systems, spreadsheets, manual checks, and disconnected tools.

This is where AI can be useful, but only if it is used carefully. In healthcare and pharma, companies cannot simply trust a black-box answer. They need proof, review trails, and human oversight.

Graph AI’s pitch is built around that idea. It wants AI to handle the heavy operational work, while experts remain in control of judgment and compliance.

Competitors and Market overview

Graph AI is entering a space with strong existing players. Some well-known names in pharmacovigilance software include Oracle Argus Safety, ArisGlobal LifeSphere Safety, and Veeva Vault Safety. Veeva has also announced Falcon Safety, an AI-focused safety operations product planned for early adopter availability in November 2026.

ArisGlobal and Veeva already serve large life sciences customers, so Graph AI will need to prove that its platform is faster, easier to adopt, and reliable in regulated environments. Its advantage may come from being AI-native from the start, instead of adding AI features on top of older workflows.

Conclusion and Key Takeaways

Graph AI’s $13.3 million Series A round shows that investors are looking closely at practical AI tools for healthcare operations, not just consumer-facing AI products.

Key takeaways –

• Graph AI raised $13.3 million in Series A funding led by Insight Partners.
• Bessemer Venture Partners also participated in the round.
• The startup was founded in 2024 and focuses on AI-powered patient safety software.
• The money will support expansion across the US and Europe.
• Graph AI competes with players like Oracle Argus, ArisGlobal LifeSphere Safety, and Veeva Safety.

Facts Input- PRNewswire